Actively Recruiting
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
Led by University of Rochester · Updated on 2026-03-24
300
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
Sponsors
U
University of Rochester
Lead Sponsor
N
National Institute on Aging (NIA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted intervention: COACH-Cog). The investigators hypothesize that for patients with dual diagnoses of ADRD and cancer, COACH-Cog will increase autonomy support of care partners and patients in the decision-making process, leading to greater acknowledgement and support of cognitive concerns and cognitive-related goals, thereby improving goal concordant care. The investigators are conducting a pilot randomized controlled trial (RCT; cluster randomized by physician) including approximately 45 oncology clinicians and 130 patient/care partner dyads evaluating the effect of COACH-Cog on care partner and patient autonomy support, care partner well-being, goal-concordance, and communication.
CONDITIONS
Official Title
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be age 65 or older
- Have a clinical diagnosis of Alzheimer's disease or related dementia (including Alzheimer's disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown subtype)
- Have a clinical diagnosis of cancer of any type or stage
- Expect a potential decision about cancer-related management as confirmed by the primary medical oncology clinician
- Have a care partner willing and able to participate in the study
- Be able to read and understand English
- Be able to provide informed consent or have a legally authorized representative to provide consent
- Care partners must be age 18 or over, able to read and understand spoken English, and able to provide informed consent
- Oncology clinicians must be affiliated with the Wilmot Cancer Institute and not planning to move or retire within 2 years
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester Wilmot Cancer Institute
Rochester, New York, United States, 14620
Actively Recruiting
Research Team
A
Allison Magnuson
CONTACT
J
Jessica Bauer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here